Baker Bros. Advisors’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.2M | Hold |
|
|||||
|
2025
Q1 | $46.1M | Hold |
|
|||||
|
2024
Q4 | $73.1M | Hold |
|
|||||
|
2024
Q3 | $87.2M | Hold |
|
|||||
|
2024
Q2 | $81M | Hold |
|
|||||
|
2024
Q1 | $57.1M | Hold |
|
|||||
|
2023
Q4 | $40.1M | Hold |
|
|||||
|
2023
Q3 | $30.5M | Hold |
|
|||||
|
2023
Q2 | $38.8M | Hold |
|
|||||
|
2023
Q1 | $34.5M | Hold |
|
|||||
|
2022
Q4 | $42.6M | Hold |
|
|||||
|
2022
Q3 | $50.6M | Hold |
|
|||||
|
2022
Q2 | $49.2M | Buy |
|
|||||
|
2022
Q1 | $34.4M | Hold |
|
|||||
|
2021
Q4 | $71M | Hold |
|
|||||
|
2021
Q3 | $73.5M | Hold |
|
|||||
|
2021
Q2 | $65.1M | Hold |
|
|||||
|
2021
Q1 | $76.3M | Buy |
|
|||||
|
2020
Q4 | $58.8M | Hold |
|
|||||
|
2020
Q3 | $62.5M | Buy |
|